Are metformin, statin and aspirin use still associated with overall mortality among colorectal cancer patients with diabetes if adjusted for one another?

被引：0
作者：
M M J Zanders
M P P van Herk-Sukel
P A J Vissers
R M C Herings
H R Haak
L V van de Poll-Franse
机构：
[1] Netherlands Comprehensive Cancer Organisation,Department of Research
[2] PHARMO Institute for Drug Outcomes Research,Department of Research
[3] Centre of Research on Psychology in Somatic Diseases (CoRPS),Department of Medical and Clinical Psychology
[4] Tilburg University,Department of Internal Medicine
[5] Máxima Medical Centre,Department of Internal Medicine, Division of General Internal Medicine
[6] Maastricht University Medical Centre+,Department of Health Services Research
[7] CAPHRI School for Public Health and Primary Care,undefined
[8] Maastricht University,undefined
来源：
British Journal of Cancer | 2015年 / 113卷
关键词：
diabetes; cancer; overall mortality; drug exposure;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：403 / 410
页数：7
相关论文
共 161 条
[1]  
Agarwal B(1999)Lovastatin augments apoptosis induced by chemotherapeutic agents in colon cancer cells Clin Cancer Res 5 2223-2229
[2]  
Bhendwal S(2010)Effect of statin therapy on colorectal cancer Gut 59 1572-1585
[3]  
Halmos B(2012)Use of aspirin postdiagnosis improves survival for colon cancer patients Br J Cancer 106 1564-1570
[4]  
Moss SF(2012)Cancer mortality reduction and metformin: a retrospective cohort study in type 2 diabetic patients Diabetes Obes Metab 14 23-29
[5]  
Ramey WG(2014)Statin use after colorectal cancer diagnosis and survival: a population-based cohort study J Clin Oncol 32 3177-3183
[6]  
Holt PR(2007)Aspirin and the risk of colorectal cancer in relation to the expression of COX-2 N Engl J Med 356 2131-2142
[7]  
Bardou M(2009)Aspirin use and survival after diagnosis of colorectal cancer JAMA 302 649-658
[8]  
Barkun A(2012)Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugs Diabetologia 55 2929-2937
[9]  
Martel M(2012)Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer Br J Cancer 106 1374-1378
[10]  
Bastiaannet E(2001)Paradoxical relations of drug treatment with mortality in older persons Epidemiology 12 682-689
12345678910